4//SEC Filing
Goldan Keith A. 4
Accession 0000950170-25-074304
CIK 0001395937other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:04 PM ET
Size
4.5 KB
Accession
0000950170-25-074304
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-05-19+3,000→ 93,746 total
Footnotes (1)
- [F1]The purchase prices ranged from $8.8465 to $9.2825.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001495411
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:04 PM ET
- Size
- 4.5 KB